1. Home
  2. ENOV vs BSTZ Comparison

ENOV vs BSTZ Comparison

Compare ENOV & BSTZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ENOV
  • BSTZ
  • Stock Information
  • Founded
  • ENOV 1995
  • BSTZ 2019
  • Country
  • ENOV United States
  • BSTZ United States
  • Employees
  • ENOV N/A
  • BSTZ N/A
  • Industry
  • ENOV Fluid Controls
  • BSTZ Trusts Except Educational Religious and Charitable
  • Sector
  • ENOV Industrials
  • BSTZ Finance
  • Exchange
  • ENOV Nasdaq
  • BSTZ Nasdaq
  • Market Cap
  • ENOV 1.6B
  • BSTZ 1.4B
  • IPO Year
  • ENOV 2008
  • BSTZ N/A
  • Fundamental
  • Price
  • ENOV $28.45
  • BSTZ $21.68
  • Analyst Decision
  • ENOV Strong Buy
  • BSTZ
  • Analyst Count
  • ENOV 6
  • BSTZ 0
  • Target Price
  • ENOV $51.00
  • BSTZ N/A
  • AVG Volume (30 Days)
  • ENOV 1.6M
  • BSTZ 303.2K
  • Earning Date
  • ENOV 08-07-2025
  • BSTZ 01-01-0001
  • Dividend Yield
  • ENOV N/A
  • BSTZ 8.31%
  • EPS Growth
  • ENOV N/A
  • BSTZ N/A
  • EPS
  • ENOV N/A
  • BSTZ 0.71
  • Revenue
  • ENOV $2,189,576,000.00
  • BSTZ N/A
  • Revenue This Year
  • ENOV $8.23
  • BSTZ N/A
  • Revenue Next Year
  • ENOV $6.18
  • BSTZ N/A
  • P/E Ratio
  • ENOV N/A
  • BSTZ $26.69
  • Revenue Growth
  • ENOV 14.40
  • BSTZ N/A
  • 52 Week Low
  • ENOV $25.47
  • BSTZ $14.11
  • 52 Week High
  • ENOV $49.83
  • BSTZ $19.43
  • Technical
  • Relative Strength Index (RSI)
  • ENOV 48.56
  • BSTZ 72.61
  • Support Level
  • ENOV $25.72
  • BSTZ $20.89
  • Resistance Level
  • ENOV $29.56
  • BSTZ $21.47
  • Average True Range (ATR)
  • ENOV 1.08
  • BSTZ 0.22
  • MACD
  • ENOV 0.22
  • BSTZ -0.00
  • Stochastic Oscillator
  • ENOV 72.86
  • BSTZ 92.98

About ENOV Enovis Corporation

Enovis Corp is a medical technology company that offers medical devices and services across the continuum of patient care, from injury prevention to joint replacement to rehabilitation after surgery, injury, or degenerative disease. Its reportable segments are Prevention & Recovery (P&R) and Reconstructive (Recon). The company generates the maximum revenue from the Prevention & Recovery segment, which includes products that are used to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports-related injuries. The Reconstructive segment provides a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and surgical productivity tools. Geographically, it derives key revenue from the U.S.

About BSTZ BlackRock Science and Technology Term Trust of Beneficial Interest

BlackRock Science and Technology Trust II is a non-diversified, closed-end management investment company. The trust's investment objectives are to provide total return and income through a combination of current income, current gains, and long-term capital appreciation. Its portfolio consists of Equity Securities, Options, Preferred Securities, Convertible Securities, Depositary Receipts, Non-U.S. Securities, Emerging Markets Investments, Restricted and Illiquid Investments, Private Company Investments, Corporate Bonds, and other investments. The trust seeks to Invest at least 80% of its total assets in equity securities issued by U.S. and non-U.S. science and technology companies in any market capitalization range from the development, advancement, and use of science and/or technology.

Share on Social Networks: